Tyrosine receptor kinase B (TrkB) protein expression in the human endometrium

Dana Anger; Bingjun Zhang; Odette Boutross-Tadross; Warren Foster
April 2007
Endocrine (1355008X);Apr2007, Vol. 31 Issue 2, p167
Academic Journal
Tyrosine kinase receptor B (TrkB) gene expression, a neurotrophic factor receptor expressed in the brain and ovary, has recently been identified in deep infiltrating endometriosis by gene array. TrkB is thought to be important in resistance to anchorage independent apoptosis (ANOIKIS) and thus could be important in the pathogenesis of endometriosis. However, TrkB protein expression in the eutopic endometrium of women with and without endometriosis is unknown. Therefore, we examined TrKB protein expression in the endometrium by Western blot (n = 50) and immunohistochemistry (n = 17). Immunoblots of endometrial biopsies were prepared from women with endometriosis (n = 21) vs. healthy controls (n = 29) undergoing benign gynecological surgery at McMaster University Medical Centre. TrkB protein expression was significantly higher in immunoblots from women with endometriosis compared to women without endometriosis. In samples of archived paraffin-embedded endometrial tissue TrkB was localized to the cytoplasm of epithelial cells of the eutopic endometrium from women with endometriosis (n = 7) and without endometriosis (n = 10). We conclude that TrkB protein is expressed in human endometrium. Our results also suggest that TrkB expression may be greater in women with endometriosis compared to women without endometriosis.


Related Articles

  • AXL and SHCI may be involved in Pathogenesis.  // Fertility Weekly;3/23/2009, p3 

    The article reports on the study regarding the examination of gene expression patterns of endometriosis-related genes in the U.S. It reveals that receptor tyrosine kinase (AXL) and SHCI genes may be potentially involved in the pathogenesis of endometriosis. It concludes that AXL may exhibit a...

  • beta-Hydroxyisovalerylshikonin induces apoptosis and G0/G1 cell-cycle arrest of endometriotic stromal cells: a preliminary in vitro study. M. Nishida; K. Nasu; T. Ueda; A. Yuge; N. Takai; H. Narahara // Human Reproduction;Nov2006, Vol. 21 Issue 11, p2850 

    BACKGROUND: Most of the current medical treatments for endometriosis aim to down-regulate the estrogen activity. However, a high recurrence rate after medical treatments has been the most significant problem. β-Hydroxyisovalerylshikonin (β-HIVS) is an ATP non-competitive inhibitor of...

  • Endothelial Cell-Specific Molecule 2 (ECSM2) Localizes to Cell-Cell Junctions and Modulates bFGF-Directed Cell Migration via the ERK-FAK Pathway. Chunwei Shi; Jia Lu; Wen Wu; Fanxin Ma; Georges, Joseph; Huang, Hanju; Balducci, James; Chang, Yongchang; Yao Huang // PLoS ONE;2011, Vol. 6 Issue 6, p1 

    Background: Despite its first discovery by in silico cloning of novel endothelial cell-specific genes a decade ago, the biological functions of endothelial cell-specific molecule 2 (ECSM2) have only recently begun to be understood. Limited data suggest its involvement in cell migration and...

  • JNK-Mediated FOXO Expression Plays a Critical Role in EGFR Tyrosine Kinase Inhibitor-Induced BIM Expression and Apoptosis. Takeuchi, Kenji; Viet, Anh Ho; Kawasaki, Katsumi; Nishio, Kazuto; Ito, Fumiaki // Journal of Cancer Therapy;Aug2012 Supplement, Vol. 3 Issue 4A, p424 

    BIM, a key pro-apoptotic member of the BCL-2 family of proteins, is essential for apoptosis triggered by tyrosine kinase inhibitors (TKIs) of the epidermal growth factor receptor (EGFR). However, the precise molecular mechanism by which EGFR-TKIs induce BIM expression has remained unclear. A...

  • Selective Akt Inhibitors Synergize with Tyrosine Kinase Inhibitors and Effectively Override Stroma-Associated Cytoprotection of Mutant FLT3-Positive AML Cells. Weisberg, Ellen; Liu, Qingsong; Zhang, Xin; Nelson, Erik; Sattler, Martin; Liu, Feiyang; Nicolais, Maria; Zhang, Jianming; Mitsiades, Constantine; Smith, Robert W.; Stone, Richard; Galinsky, Ilene; Nonami, Atsushi; Griffin, James D.; Gray, Nathanael // PLoS ONE;Feb2013, Vol. 8 Issue 2, p1 

    Objectives: Tyrosine kinase inhibitor (TKI)-treated acute myeloid leukemia (AML) patients commonly show rapid and significant peripheral blood blast cell reduction, however a marginal decrease in bone marrow blasts. This suggests a protective environment and highlights the demand for a better...

  • Expression of vascular endothelial growth factor and its receptors in endometriosis. Noori, E.; Nasri, S.; Mahdian, S.; Janan, A.; Aghajanpour, S.; Moini, A.; Ramazanali, F.; Lakpour, M.R.; Aflatoonian, R. // Iranian Journal of Reproductive Medicine;AprSupp, p54 

    Introduction: Endometriosis is a gynecological disease that affects women of reproductive age. This disease is defined by the growth of endometrium-like tissue outside the uterine cavity. Several factors have been founded that play an important role in the pathogenesis of endometriosis. The most...

  • Tyrosine Kinase Inhibitors Gefitinib, Lapatinib and Sorafenib Induce Rapid Functional Alterations in Breast Cancer Cells. Carloni, S.; Fabbri, F.; Brigliadori, G.; Ulivi, P.; Silvestrini, R.; Amadori, D.; Zoli, W. // Current Cancer Drug Targets;Jun2010, Vol. 10 Issue 4, p422 

    Alterations in tyrosine kinase expression or functionality have been linked to tumor growth, and detailed analysis of tyrosine kinase pathways has led to the development of novel anticancer drugs based on their inhibition. The aim of the present work was to examine the cytotoxicity and cellular...

  • BAY 61-3606, CDKi, and sodium butyrate treatments alter gene expression in human vestibular schwannomas and cause cell death in vitro. Mitra, Rohan; Bhagavatula, Indira Devi; Gope, Rajalakshmi // Ecancermedicalscience;2012, Vol. 6 Issue 271-285, p1 

    Background: Disrupted kinase and signaling pathways are found in many human cancers and they are implicated in carcinogenesis. Therefore, kinases have been important targets for the development of cancer therapeutics. Human vestibular schwannomas (VS) are the third most common intracranial...

  • Epha2 is a critical oncogene in melanoma. Udayakumar, D; Zhang, G; Ji, Z; Njauw, C-N; Mroz, P; Tsao, H // Oncogene;12/15/2011, Vol. 30 Issue 50, p4921 

    EphA2 is a member of the Eph family of receptor tyrosine kinases and is highly expressed in many aggressive cancer types, including melanoma. We recently showed that EphA2 is also upregulated by ultraviolet radiation and is able to induce apoptosis. These findings suggest that EphA2 may have...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics